1. Sensus Healthcare is being investigated for securities law violations. 2. The investigation follows disappointing Q2 2025 financial results. 3. Sensus reported a 20.7% decline in revenues year-over-year. 4. Shares fell over 35.2% following the financial report's release. 5. The Law Firm seeks to represent affected shareholders.
The significant revenue decline and stock drop indicate severe market loss. Historical cases of poor earnings lead to sustained stock price declines.
The news directly pertains to SRTS's share price, impacting investor confidence significantly.
Investor reaction can lead to immediate stock volatility, resembling previous rapid drops post-earnings reports.
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sensus Healthcare, Inc. ("Sensus" or "the Company") (NASDAQ: SRTS) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Sensus reported its Q2 2025 financial results on August 7, 2025. The Company reported a significant miss on earnings per share against estimates, and revenues that fell 20.7% year-over-year. The Company blamed the revenue decrease on lower sales to a large customer. Based on this news, shares of Sensus fell by more than 35.2% on the next day.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250824561702/en/
The Schall Law Firm
Brian Schall, Esq.
310-301-3335
info@schallfirm.com
www.schallfirm.com